ANDA 40184, held by Watson Labs. Trihexyphenidyl Hydrochloride.
As of Nov 16, 2026, ANDA 40184 (Trihexyphenidyl Hydrochloride), held by Watson Labs, was first approved by FDA on Feb 6, 1998, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 6, 1998 | Original application | Approved |
| Trihexyphenidyl Hydrochloride2MG · tablet;oral | Trihexyphenidyl Hydrochloride | Discontinued |
| Trihexyphenidyl Hydrochloride5MG · tablet;oral | Trihexyphenidyl Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters